UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intracellular origin and ultrastructure of platelet‐derived microparticles

Journal of thrombosis and haemostasis, 2017-08, Vol.15 (8), p.1655-1667

2017

Volltextzugriff (PDF)

Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages

Journal of thrombosis and haemostasis, 2015-08, Vol.13 (8), p.1416-1427

2015

Volltextzugriff (PDF)

The disulfide isomerase ERp57 is required for fibrin deposition in vivo

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1890-1897

2014

Volltextzugriff (PDF)

Platelet‐delivered factor VIII provides limited resistance to anti‐factor VIII inhibitors

Journal of thrombosis and haemostasis, 2008-07, Vol.6 (7), p.1160-1166

2008

Volltextzugriff (PDF)

Platelet factor 4 platelet levels are inversely correlated with steady‐state platelet counts and with platelet transfusion needs in pediatric leukemia patients

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1442-1446

2012

Volltextzugriff (PDF)

Platelet and monocyte antigenic complexes in the pathogenesis of heparin‐induced thrombocytopenia (HIT)

Journal of thrombosis and haemostasis, 2009-07, Vol.7 (1), p.249-252

2009

Volltextzugriff (PDF)

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications

Blood, 2006-03, Vol.107 (6), p.2346-2353

2006

Volltextzugriff (PDF)

PB1359 Fc Modified KKO Blocks Thrombosis in Heparin-Induced Thrombocytopenia (HIT), But not in Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101509, Article 101509

2023

Volltextzugriff (PDF)

PB0142 FVIII-Containing Immune Complexes Interrupt Platelet Aggregation in an Ex-Vivo Model of Primary Hemostasis

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101090, Article 101090

2023

Volltextzugriff (PDF)

PB0351 Complement Activating Properties of Heparin Induced Thrombocytopenia (HIT) Antibodies as Surrogate Markers for Functional Assays

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101478, Article 101478

2023

Volltextzugriff (PDF)

OC 66.4 Platelet Factor 4 (Pf4) Enhances Bacterial Uptake and Clearance by the Endothelium, Contributing to Improved Outcomes in Sepsis

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100500, Article 100500

2023

Volltextzugriff (PDF)

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia

Blood, 2005-01, Vol.105 (1), p.131-138

2005

Volltextzugriff (PDF)

High-dose intravenous immunoglobulins for lupus nephritis — a salvage immunomodulation

Lupus, 2001-01, Vol.10 (3), p.209-213

2001

Volltextzugriff (PDF)

OC 76.1 Chadox1 Exposure-Induced Neutrophil-Activating Peptide 2 (NAP2) Antibodies: Murine-Based Insights into the Pathogenesis of Thrombosis with Thrombocytopenia Syndrome (TTS)

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100348, Article 100348

2023

Volltextzugriff (PDF)

Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin

Blood, 2004-11, Vol.104 (10), p.3173-3180

2004

Volltextzugriff (PDF)

High dose intravenous immunoglobulins: a new step in the treatment of systemic lupus erythematosus

The Israel Medical Association journal, 2000-05, Vol.2 (5), p.388-392

2000

Volltextzugriff (PDF)

Efficacy of IVIG affinity‐purified anti‐double‐stranded DNA anti‐idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus

International immunology, 2002-11, Vol.14 (11), p.1303-1311

2002

Volltextzugriff (PDF)

Immunization of Low-density Lipoprotein Receptor Deficient (LDL-RD) Mice with Heat Shock Protein 65 (HSP-65) Promotes Early Atherosclerosis

Journal of autoimmunity, 2000-03, Vol.14 (2), p.115-121

2000

Volltextzugriff (PDF)

Surface Heparinization of Polyurethane Via Bromoalkylation of Hard Segment Nitrogens

Biomacromolecules, 2006-01, Vol.7 (1), p.317-322

2006

Volltextzugriff (PDF)

Intravenous immunoglobulin treatment of lupus nephritis

Seminars in arthritis and rheumatism, 2000-04, Vol.29 (5), p.321-327

2000

Volltextzugriff (PDF)

PF4/heparin complexes are T cell–dependent antigens

Blood, 2005-08, Vol.106 (3), p.929-931

2005

Volltextzugriff (PDF)

Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases

Pharmacology, 2001-01, Vol.62 (3), p.133-137

2001

Volltextzugriff (PDF)

The Role of Surface PF4: Glycosaminoglycan Complexes in the Pathogenesis of Heparin-Induced Thrombocytopenia (HIT)

Pathophysiology of haemostasis and thrombosis, 2006-01, Vol.35 (1-2), p.46-49

2006

Volltextzugriff (PDF)

Induction of Biologically Active Antineutrophil Cytoplasmic Antibodies by Immunization with Human Apoptotic Polymorphonuclear Leukocytes

Clinical immunology (Orlando, Fla.), 2002-04, Vol.103 (1), p.69-78

2002

Volltextzugriff (PDF)

Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus

Journal of rheumatology, 1997-12, Vol.24 (12), p.2330

1997

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(55)

Sprache

Englisch
(51)
Slowakisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Humans
(32)
Animals
(15)
Hematology
(14)
Female
(13)
Mice
(12)
Adult
(11)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Middle Aged
(9)
Male
(8)
Cardiovascular System & Cardiology
(7)
Heparin - Adverse Effects
(7)
Peripheral Vascular Disease
(7)
Platelet Factor 4 - Immunology
(7)
Thrombocytopenia - Chemically Induced
(7)
Hematologic And Hematopoietic Diseases
(6)
Rheumatology
(6)
Heparin - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intracellular origin and ultrastructure of platelet‐derived microparticles

Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages

The disulfide isomerase ERp57 is required for fibrin deposition in vivo

Platelet‐delivered factor VIII provides limited resistance to anti‐factor VIII inhibitors

Platelet factor 4 platelet levels are inversely correlated with steady‐state platelet counts and with platelet transfusion needs in pediatric leukemia patients

Platelet and monocyte antigenic complexes in the pathogenesis of heparin‐induced thrombocytopenia (HIT)

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications

PB1359 Fc Modified KKO Blocks Thrombosis in Heparin-Induced Thrombocytopenia (HIT), But not in Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

PB0142 FVIII-Containing Immune Complexes Interrupt Platelet Aggregation in an Ex-Vivo Model of Primary Hemostasis

PB0351 Complement Activating Properties of Heparin Induced Thrombocytopenia (HIT) Antibodies as Surrogate Markers for Functional Assays

OC 66.4 Platelet Factor 4 (Pf4) Enhances Bacterial Uptake and Clearance by the Endothelium, Contributing to Improved Outcomes in Sepsis

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia

High-dose intravenous immunoglobulins for lupus nephritis — a salvage immunomodulation

OC 76.1 Chadox1 Exposure-Induced Neutrophil-Activating Peptide 2 (NAP2) Antibodies: Murine-Based Insights into the Pathogenesis of Thrombosis with Thrombocytopenia Syndrome (TTS)

Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin

High dose intravenous immunoglobulins: a new step in the treatment of systemic lupus erythematosus

Efficacy of IVIG affinity‐purified anti‐double‐stranded DNA anti‐idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus

Immunization of Low-density Lipoprotein Receptor Deficient (LDL-RD) Mice with Heat Shock Protein 65 (HSP-65) Promotes Early Atherosclerosis

Surface Heparinization of Polyurethane Via Bromoalkylation of Hard Segment Nitrogens

Intravenous immunoglobulin treatment of lupus nephritis

PF4/heparin complexes are T cell–dependent antigens

Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases

The Role of Surface PF4: Glycosaminoglycan Complexes in the Pathogenesis of Heparin-Induced Thrombocytopenia (HIT)

Induction of Biologically Active Antineutrophil Cytoplasmic Antibodies by Immunization with Human Apoptotic Polymorphonuclear Leukocytes

Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus

Suchergebnisse filtern